Vertex Pharmaceuticals (VRTX) Cash from Operations Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 74.39% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 3.23% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 158.60% |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.39% |
| Dec 31, 2025 | -14.81% |
| Sep 30, 2025 | -9.37% |
| Jun 30, 2025 | 128.59% |
| Mar 31, 2025 | -37.33% |
| Dec 31, 2024 | 149.19% |
| Sep 30, 2024 | 7.99% |
| Jun 30, 2024 | -430.89% |
| Mar 31, 2024 | 45.19% |
| Dec 31, 2023 | -78.25% |
| Sep 30, 2023 | 32.75% |
| Jun 30, 2023 | -0.47% |
| Mar 31, 2023 | -5.89% |
| Dec 31, 2022 | 8.38% |
| Sep 30, 2022 | 3.05% |
| Jun 30, 2022 | 670.76% |
| Mar 31, 2022 | 3.82% |
| Dec 31, 2021 | 102.43% |
| Sep 30, 2021 | 2.14% |
| Jun 30, 2021 | -119.23% |
| Mar 31, 2021 | 12.91% |
| Dec 31, 2020 | 10.21% |
| Sep 30, 2020 | 171.14% |
| Jun 30, 2020 | 123.94% |
| Mar 31, 2020 | 151.15% |
| Dec 31, 2019 | 41.77% |
| Sep 30, 2019 | -12.21% |
| Jun 30, 2019 | 44.15% |
| Mar 31, 2019 | 28.55% |
| Dec 31, 2018 | 38.27% |
| Sep 30, 2018 | 124.21% |
| Jun 30, 2018 | 77.10% |
| Mar 31, 2018 | -4.91% |
| Dec 31, 2017 | 57.20% |
| Sep 30, 2017 | 159.06% |
| Jun 30, 2017 | 344.57% |
| Mar 31, 2017 | 1,855.25% |
| Dec 31, 2016 | 396.60% |
| Sep 30, 2016 | 205.77% |
| Jun 30, 2016 | 137.06% |